Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/28/2025

Safe Combination of Fluconazole and Co-Amoxiclav

Introduction to Safe Use

  • The American College of Clinical Pharmacology recommends that fluconazole and co-amoxiclav can be safely combined without significant drug-drug interactions or increased risk of adverse outcomes, as fluconazole inhibits CYP2C9, CYP2C19, and to a lesser extent CYP3A4 enzymes, but amoxicillin/clavulanic acid is primarily eliminated renally 1

Safety Profile and Monitoring

  • The Infectious Diseases Society of America notes that co-amoxiclav combined with warfarin shows a relative risk of 4.4 for bleeding complications, but this interaction is specific to vitamin K antagonists and does not extend to fluconazole combinations 2
  • The National Kidney Foundation recommends assessing renal function, as both drugs require dose adjustment in renal impairment, with fluconazole dosing reduced by 50% when creatinine clearance is <50 mL/min 1
  • The American Gastroenterological Association suggests monitoring for gastrointestinal effects, as co-amoxiclav commonly causes diarrhea and nausea, and fluconazole at higher doses (>800 mg/day) can also cause GI toxicity 3

Special Considerations

  • The American Heart Association advises that patients on warfarin require INR monitoring every 3-5 days during the first 2 weeks when combined with co-amoxiclav, due to a significant increase in bleeding risk (RR 4.4) 2
  • The Infectious Diseases Society of America recommends that high-dose fluconazole regimens (≥800 mg/day) for serious infections should use divided dosing to minimize GI side effects that could be compounded by co-amoxiclav 3
  • The American Society of Transplantation suggests that immunocompromised patients, such as transplant recipients, should have both renal function and infection response monitored more closely 4

Practical Guidance

  • The European Society of Clinical Microbiology and Infectious Diseases recommends verifying the indication for both drugs, ensuring fluconazole is treating a documented or suspected fungal infection and co-amoxiclav is appropriate for the bacterial infection 6
  • The National Institute of Diabetes and Digestive and Kidney Diseases advises checking renal function and adjusting doses of both medications if creatinine clearance <50 mL/min 4